Skip to main navigation Skip to search Skip to main content

A Long-acting Human Growth Hormne (VRS-317) in Pre-pubertal Children with Growth Hormone Deficiency: A Randomized, Open-label, Multi-center, Phase 1b/2a Study of Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficac

Project: Research

Project Details

StatusFinished
Effective start/end date09/27/12 → 09/23/15

Funding

  • Versartis Incorporated: $49,480.00